Literature DB >> 24983543

Deteriorating renal function and clinical outcomes in HIV-positive persons.

Amanda Mocroft1, Lene Ryom, Josip Begovac, Antonella D'Arminio Monforte, Anne Vassilenko, Jose Gatell, Eric Florence, Vidar Ormaasen, Ole Kirk, Jens D Lundgren.   

Abstract

OBJECTIVES: To determine the relationship between measures of renal function [current estimated glomerular filtration rate (eGFR) and proportion of follow-up with a low eGFR (%FU ≤60 ml/min)] and fatal/ nonfatal AIDS, non-AIDS events and all-cause mortality.
DESIGN: An observational, longitudinal cohort study of 12 155 persons from EuroSIDA.
METHODS: Persons with at least one eGFR measurement after 1 January 2004, using the CKD-EPI formula, were included. Poisson regression analyses were used to determine whether current eGFR or %FU of 60 ml/min or less were independent prognostic markers for clinical events.
RESULTS: During 61 425 person-years of follow-up (PYFU), the crude incidence of deaths was 11.1/1000 PYFU [95% confidence interval (CI) 10.0-12.1] at current eGFR more than 90 ml/min and 199.6 (95% CI 1144.3-254.3/1000 PYFU) when current eGFR was 30 ml/min or less. Corresponding figures for AIDS were 12.2 (11.1-13.3) and 63.9 (36.5-103.7) and for non-AIDS were 16.0 (14.8-17.3) and 203.6 (147.7-259.5). After adjustment, current eGFR of 30 ml/min or less was a strong predictor of death [adjusted incidence rate ratios (aIRR) 4.35; 95% CI 3.20-5.91] and non-AIDS events (3.63; 95% CI 2.57-5.13), although the relationship with AIDS was less strong (1.45; 95% CI 1.01-2.08). After adjustment, %FU of 60 ml/min or less was associated with a 22% increased incidence of death (aIRR 1.22 per 10% longer; 95% CI 1.18-1.27), a 13% increased incidence of non-AIDS events (95% CI 1.08-1.18) and a 15% increased incidence of AIDS events (95% CI 1.06-1.24).
CONCLUSION: Both current eGFR and %FU of 60 ml/min or less were associated with death and non-AIDS events in HIV-positive persons. Our findings highlight the association between underlying renal dysfunction and morbidity and mortality in HIV infection, although reverse causality cannot be excluded.

Entities:  

Mesh:

Year:  2014        PMID: 24983543     DOI: 10.1097/QAD.0000000000000134

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.

Authors:  S Leone; M Prosperi; S Costarelli; P Nasta; F Maggiolo; S Di Giambenedetto; A Saracino; M Di Pietro; A Gori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-06       Impact factor: 3.267

Review 2.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

3.  Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

Authors:  Lene Ryom; Jens D Lundgren; Mike Ross; Ole Kirk; Matthew Law; Philippe Morlat; Eric Fontas; Colette Smit; Christoph A Fux; Camilla I Hatleberg; Stéphane de Wit; Caroline A Sabin; Amanda Mocroft
Journal:  J Infect Dis       Date:  2016-08-02       Impact factor: 5.226

4.  Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV.

Authors:  Sanjiv M Baxi; Rebecca Scherzer; Vasantha Jotwani; Michelle M Estrella; Alison G Abraham; Chirag R Parikh; Michael R Bennett; Mardge H Cohen; Marek J Nowicki; Deborah R Gustafson; Anjali Sharma; Mary A Young; Michael G Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

5.  Comparison of Various Equations for Estimating GFR in Malawi: How to Determine Renal Function in Resource Limited Settings?

Authors:  Nicola Glaser; Andreas Deckert; Sam Phiri; Dietrich Rothenbacher; Florian Neuhann
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

6.  Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Authors:  Amanda Mocroft; Jens D Lundgren; Michael Ross; Matthew Law; Peter Reiss; Ole Kirk; Colette Smith; Deborah Wentworth; Jacqueline Neuhaus; Christoph A Fux; Olivier Moranne; Phillipe Morlat; Margaret A Johnson; Lene Ryom
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

7.  Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

Authors:  Carmine Rossi; Janet Raboud; Sharon Walmsley; Curtis Cooper; Tony Antoniou; Ann N Burchell; Mark Hull; Jason Chia; Robert S Hogg; Erica E M Moodie; Marina B Klein
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

8.  Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia.

Authors:  Temesgen Fiseha; Angesom Gebreweld
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 9.  A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV.

Authors:  Davide Fiore Bavaro; Paola Laghetti; Mariacristina Poliseno; Nicolò De Gennaro; Francesco Di Gennaro; Annalisa Saracino
Journal:  Diagnostics (Basel)       Date:  2021-11-04

Review 10.  The renal patient seen by non-renal physicians: the kidney embedded in the 'milieu intérieur'.

Authors:  Felix Perez-Villa; Marie Hélène Lafage-Proust; Eveline Gielen; Alberto Ortiz; Goce Spasovski; Àngel Argilés
Journal:  Clin Kidney J       Date:  2020-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.